The minister Nisia Trindade (Health) announced this Tuesday (2) the single-dose HPV vaccinea virus associated with more than 90% of cervical cancer cases. The vaccine will be made available in the Unified Health System (SUS) for children and adolescents between 9 and 14 years old.
Immunosuppressed people and victims of sexual violence, who can also receive the vaccine on the public network, continue with the previous schedule (two or three doses).
The measure follows a recommendation from the World Health Organization (WHO). In 2022, researchers reviewed evidence for the effectiveness of more than one dose. It was concluded that a single dose already offers significant protection against HPV.
The WHO also believes that the vaccination schedule with just one dose can increase vaccination coverage.
Read too: Anderson Leonardo, vocalist of Molejo, shows clinical improvement, says new medical bulletin
The Ministry of Health also asked states and municipalities to carry out campaigns to vaccinate young people up to 19 years of age who have not yet been vaccinated against HPV.
In addition to the single dose, the folder also included a new group of people among those prioritized to receive the vaccine: people with recurrent respiratory papillomatosis (PPR), of any age.
Read too: Experts view cocaine vaccine with skepticism
